This review explores how AI enhances drug screening and personalized therapy in neuropharmacology, highlighting advanced micro/nanotechnology applications.
Key Points
The aim is to examine how artificial intelligence and micro/nanotechnology can improve neuropharmacology research strategies.
Systematic review of microfluidic brain chips and nanodelivery systems.
Analysis of AI applications in drug development.
Examination of efficacy assessment and personalized therapeutic decision-making.
AI integration enhances predictive modeling and data analysis in neuropharmacology.
Micro/nanotechnology improves drug delivery efficiency and viably models neurological diseases.
The combination of AI and advanced technologies supports better outcomes in therapeutic strategies.